المؤلفون: A. Vorobyova V., B. Bondarenko B., V. Bart A., M. Malgina P., V. Dorofeykov V., E. Kuleshova V., А. Воробьева В., Б. Бондаренко Б., В. Барт А., М. Мальгина П., В. Дорофейков В., Э. Кулешова В.

المصدر: Translational Medicine; Том 6, № 3 (2019); 15-24 ; Трансляционная медицина; Том 6, № 3 (2019); 15-24 ; 2410-5155 ; 2311-4495 ; 10.18705/2311-4495-2019-6-3

مصطلحات موضوعية: ischemic heart disease, stable angina, percutaneous coronary intervention, myocardial injury, troponin, cardiac events, стабильная ИБС, чрескожное коронарное вмешательство (ЧКВ), повреждение миокарда, тропонин, кардиальные события

وصف الملف: application/pdf

Relation: https://transmed.almazovcentre.ru/jour/article/view/456/339; Brener SJ, Ellis SG, Schneider J et al. Frequency and Long-Term Impact of Myonecrosis After Coronary Stenting. Eur Heart J. 2002;23(11):869–876.; Кулешова Э.В., Дорофейков В.В., Воробьева А.В. и др Микроповреждения миокарда при коронарной баллонной ангиопластике (обзор литературы). Артериальная гипертензия 2010;16(6):535–541.; Wang TY, Peterson ED, Dai D et al. Patterns of Cardiac Marker Surveillance After Elective Percutaneous Coronary Intervention and Implications for the Use of Periprocedural Myocardial Infarction as a Quality Metric: A Report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol. 2008;51(21):2068–2074.; Jaffe R, Charron T, Puley G et al. Microvascular Obstruction and the No-Refl ow Phenomenon After Percutaneous Coronary Intervention. Circulation. 2008;117(24): 3152–3156.; Дорофейков В.В., Кулешова Э.В., Воробьева А.В. и др. Лабораторная диагностика микроповреждений миокарда во время коронарной баллонной ангиопластики со стентированием. Клиническая лабораторная диагностика. 2011;2:15–18.; Воробьева А.В., Бондаренко Б.Б., Барт В.А., и др. О факторах повреждения миокарда при плановом чрескожном коронарном вмешательстве. Вестник Санкт-Петербургского университета. Медицина. 2014; 1:168–179.; Buturak A, Degirmencioglu A, Surgit O et al. Rise of Serum Troponin Levels Following Uncomplicated Elective Percutaneous Coronary Interventions in Patients Without Clinical and Procedural Signs Suggestive of Myocardial Necrosis. Postepy Kardiol Interwencyjnej. 2016;12(1):41–48.; Thygesen K, Alpert JS, Jaffe AS, et al, Executive Group on Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Defi nition of Myocardial Infarction (2018). Glob Heart. 2018;13(4):305–338.; Feldman DN, Kim L, Rene AG et al. Prognostic Value of Cardiac Troponin-I or Troponin-T Elevation Following Nonemergent Percutaneous Coronary Intervention: A Meta-Analysis. Catheter Cardiovasc Interv. 2011;77(7): 1020–1030.; Omland T, Pfeffer MA, Solomon SD et al. Prognostic Value of Cardiac Troponin I Measured with a Highly Sensitive Assay in Patients with Stable Coronary Artery Disease. J Am Coll Cardiol. 2013;61(12):1240–1249.; Everett BM, Brooks MM, Vlachos HE et al. Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. N Engl J Med. 2015;373(7):610–620.; Zeitouni M, Silvain J, Guedeney P et al. Periprocedural Myocardial Infarction and Injury in Elective Coronary Stenting. Eur Heart J. 2018;39(13):1100–1109.; Holmes DR Jr, Berger PB. Troponisms, Necrosettes, Enzyme Leaks, Creatinine Phosphokinase Bumps, and Infarctlets: What’s Behind This New Lexicon and What Does It Add? Circulation. 2001;104(6):627–629.; White HD. Pathobiology of Troponin Elevations: Do Elevations Occur with Myocardial Ischemia As Well As Necrosis? J Am Coll Cardiol. 2011;57(24):2406–2408.; Zhang M, He H, Wang ZM et al. Diagnostic and Prognostic Value of Minor Elevated Cardiac Troponin Levels for Percutaneous Coronary Intervention-Related Myocardial Injury: A Prospective, Single-Center and Double-Blind Study. J Biomed Res. 2014;28(2):98–107.; Ndrepepa G, Colleran R, Braun S et al. High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016;68(21): 2259–2268.; Миронова О. Ю. Повышение маркеров некроза миокарда вследствие проведения плановой ангиопластики коронарных артерий и однолетний прогноз. Кардиологический вестник. 2015; 10 (1): 58–67.; Орлова А.Ф., Лейтес И.В., Черникова И.В. Пробы с физической нагрузкой. Методическое пособие по велоэргометрии. Барнаул, 2002.с.37.; Windecker S, Kolh P, Alfonso F et al. 2014 ESC/ EACTS Guidelines on Myocardial Revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the Special Contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619.; Guidelines for Percutaneous Transluminal Coronary Angioplasty. A Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 1988;12(2):529–545.; Farooq V, Vergouwe Y, Räber L et al. Combined Anatomical and Clinical Factors for the Long-Term Risk Stratifi cation of Patients Undergoing Percutaneous Coronary Intervention: The Logistic Clinical SYNTAX Score. Eur Heart J. 2012;33(24):3098–3104.; Fitzgibbon GM, Burggraf GW, Groves TD et al. A Double Master’s Two-Step Test: Clinical, Angiographic and Hemodynamic Correlation. Ann Intern Med. 1971; 74 (4): 509–517.; Nienhuis MB, Ottervanger JP, Bilo HJ et al. Prognostic Value of Troponin After Elective Percutaneous Coronary Intervention: A Meta-Analysis. Catheter Cardiovasc Interv. 2008;71(3):318–324.; De Labriolle A, Lemesle G, Bonello L et al. Prognostic Signifi cance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery. Am J Cardiol. 2009;103(5):639–645.; Testa L, Van Gaal WJ, Biondi Zoccai GG et al. Myocardial Infarction After Percutaneous Coronary Intervention: A Meta-Analysis of Troponin Elevation Applying the New Universal Defi nition. QJM. 2009;102(6):369–378.; Kini AS, Lee P, Marmur JD et al. Correlation of Postpercutaneous Coronary Intervention Creatine KinaseMB and Troponin I Elevation in Predicting Mid-Term Mortality. Am J Cardiol. 2004;93(1):18 –23.; Zimarino M, Cicchitti V, Genovesi E et al. Isolated Troponin Increase After Percutaneous Coronary Interventions: Does It Have Prognostic Relevance? Atherosclerosis. 2012;221(2):297–302.; Hubacek J, Basran RS, Shrive FM et al. Prognostic Implications of C-Reactive Protein and Troponin Following Percutaneous Coronary Intervention. Can J Cardiol. 2009; 25(2):e42–e47.; Frӧhlich GM, Leistner DM. The Relevance of Periprocedural Troponin Rise: The Never Ending Story! Open Heart. 2017;4(2):e000590.; Coronary Angioplasty Versus Medical Therapy for Angina: The Second Randomised Intervention Treatment of Angina (RITA-2) Trial. RITA-2 Trial Participants. Lancet. 1997; 350(9076):461–468.; Serruys PW, Unger F, Sousa JE et al. Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease. N Engl J Med. 2001; 344(15): 1117–1124.; Holubkov R, Laskey WK, Haviland A et al. Angina 1 Year After Percutaneous Coronary Intervention: A Report from the NHLBI Dynamic Registry. Am Heart J. 2002;144(5):826–833.; Henderson RA, Pocock SJ, Clayton TC et al. Seven-Year Outcome in the RITA-2 Trial: Coronary Angioplasty Versus Medical Therapy. J Am Coll Cardiol. 2003; 42(7):1161–1170.; Shah BR, Cowper PA, O’Brien SM et al. Patterns of Cardiac Stress Testing After Revascularization in Community Practice. J Am Coll Cardiol. 2010;56(16):1328–1334.; Tavella R, Ranasinghe I, Zeitz C et al. Post-Percutaneous Coronary Intervention Angina: A New Performance Measure? JACC Cardiovasc Interv. 2015;8(12):1639–1640.; Serruys PW, Chevalier B, Sotomi Y et al. Comparison of an Everolimus-Eluting Bioresorbable Scaffold with an Everolimus-Eluting Metallic Stent for the Treatment of Coronary Artery Stenosis (ABSORB II): A 3 Year, Randomised, Controlled, Single-Blind, Multicentre Clinical Trial. Lancet. 2016;388(10059):2479–2491.; Stone GW, Ellis SG, Gori T et al. Blinded Outcomes and Angina Assessment of Coronary Bioresorbable Scaffolds: 30-Day and 1-Year Results from the ABSORB IV Randomised Trial. Lancet. 2018;392(10157):1530–1540.; Neumann FJ, Sousa-Uva M, Ahlsson A et al. 2018 ESC/EACTS Guidelines on Myocardial Revascularization. Eur Heart J. 2019;40(2):87–165.; Al-Lamee R, Thompson D, Dehbi HM et al. Percutaneous Coronary Intervention in Stable Angina (ORBITA): A Double-Blind, Eandomised Controlled Trial. Lancet. 2018;391(10115):31–40.; Tsunoda R, Sakamoto T, Kojima S et al. Recurrence of Angina Pectoris After Percutaneous Coronary Intervention Is Reduced By Statins in Japanese Patients. J Cardiol. 2011;58(3):208–215.; https://transmed.almazovcentre.ru/jour/article/view/456

الاتاحة: https://transmed.almazovcentre.ru/jour/article/view/456
https://doi.org/10.18705/2311-4495-2019-6-3-15-24